Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2/3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Endocrine 1

Conditions

Neoplasms 6Anxiety Disorders 4Breast Neoplasms 3Motor Activity 2Fatigue 2Depression 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Sleep Initiation and Maintenance Disorders 1Prostatic Neoplasms 1Parasomnias 1Pain 1Ovarian Neoplasms 1Muscle Weakness 1Multiple Endocrine Neoplasia Type 1 1Leukemia 1Head and Neck Neoplasms 1Caregiver Burden 1Cancer Pain 1

Interventions

Exercise 234Resistance Training 32High-Intensity Interval Training 20Surveys and Questionnaires 14Methods 13Exercise Therapy 13Walking 12Preoperative Exercise 12Diet 12Control Groups 12Standard of Care 11Nutritional Status 9Nutrition Assessment 7Counseling 7Motivational Interviewing 5Diet Therapy 5Physical Therapy Modalities 4Nutritional Support 4Fitness Trackers 4Educational Status 4Cognitive Behavioral Therapy 4Behavior Therapy 4methyl hydroxyethyl cellulose 3Wearable Electronic Devices 3Therapeutics 3Rehabilitation 3Palliative Care 3Metformin 3Exercise Test 3Diet, Mediterranean 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Motor Activity × Autogenic Training × Clear all
NCT02873559 2024-05-29

PROGRESS

University Hospital, Gentofte, Copenhagen

Phase 2/3 Completed
192 enrolled
Endocrine

Motor Activity, Multiple Endocrine Neoplasia Type 1, Muscle Weakness

NCT00740038 2017-02-23

Support for People Undergoing Chemotherapy

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Completed
471 enrolled

Motor Activity, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡